DEVOS, D., J. LABREUCHE, O. RASCOL, J.-C. CORVOL, A. DUHAMEL, P. Guyon DELANNOY, W. POEWE, Y. COMPTA, N. PAVESE, E. RŮŽIČKA, P. DUŠEK, B. POST and at. ALL. Trial of Deferiprone in Parkinson’s Disease. The New England Journal of medicine. USA: Massachusetts Medical Society, 2022, vol. 387, NA, p. 2045-2055. ISSN 1533-4406. Available from: https://dx.doi.org/10.1056/NEJMoa2209254. |
Other formats:
BibTeX
LaTeX
RIS
@article{2243480, author = {Devos, D. and Labreuche, J. and Rascol, O. and Corvol, J.andC. and Duhamel, A. and Delannoy, P. Guyon and Poewe, W. and Compta, Y. and Pavese, N. and Růžička, E. and Dušek, P. and Post, B. and all, at.}, article_location = {USA}, article_number = {NA}, doi = {http://dx.doi.org/10.1056/NEJMoa2209254}, keywords = {Parkinson’s Disease; neurodegenerative disorder; FAIRPAK II; clinical trial;}, language = {eng}, issn = {1533-4406}, journal = {The New England Journal of medicine}, title = {Trial of Deferiprone in Parkinson’s Disease}, url = {https://www.nejm.org/doi/full/10.1056/NEJMoa2209254}, volume = {387}, year = {2022} }
TY - JOUR ID - 2243480 AU - Devos, D. - Labreuche, J. - Rascol, O. - Corvol, J.-C. - Duhamel, A. - Delannoy, P. Guyon - Poewe, W. - Compta, Y. - Pavese, N. - Růžička, E. - Dušek, P. - Post, B. - all, at. PY - 2022 TI - Trial of Deferiprone in Parkinson’s Disease JF - The New England Journal of medicine VL - 387 IS - NA SP - 2045-2055 EP - 2045-2055 PB - Massachusetts Medical Society SN - 15334406 KW - Parkinson’s Disease KW - neurodegenerative disorder KW - FAIRPAK II KW - clinical trial; UR - https://www.nejm.org/doi/full/10.1056/NEJMoa2209254 N2 - BACKGROUND Iron content is increased in the substantia nigra of persons with Parkinson’s disease and may contribute to the pathophysiology of the disorder. Early research suggests that the iron chelator deferiprone can reduce nigrostriatal iron content in persons with Parkinson’s disease, but its effects on disease progression are unclear. ER -
DEVOS, D., J. LABREUCHE, O. RASCOL, J.-C. CORVOL, A. DUHAMEL, P. Guyon DELANNOY, W. POEWE, Y. COMPTA, N. PAVESE, E. RŮŽIČKA, P. DUŠEK, B. POST and at. ALL. Trial of Deferiprone in Parkinson’s Disease. \textit{The New England Journal of medicine}. USA: Massachusetts Medical Society, 2022, vol.~387, NA, p.~2045-2055. ISSN~1533-4406. Available from: https://dx.doi.org/10.1056/NEJMoa2209254.
|